Hadia Almahli

Hadia Almahli is a Lecturer at the North Wales Medical School, with a research focus on medicinal chemistry and drug discovery. She has held academic positions at the University of Oxford, University of Cambridge, University College London, and the University of Sussex, contributing to pharmaceutical sciences through innovative teaching and research.

Education:

• BSc in Pharmaceutical Sciences, Aleppo University
• MSc in Medicinal Chemistry, Paris-Sud University
• PhD in Medicinal Chemistry, Paris-Sud University
• Postgraduate Certificate in Higher Education Teaching (PGCHET), University of Sussex
• Fellowship with the UK Higher Education Academy (FHEA)

Her research spans the development of anti-viral drugs, breast cancer and anti-HIV treatments, therapies for neglected diseases like Chagas disease, anti-tuberculosis drugs, and new-generation antibiotics. She also explores diagnostic methods for neurodegenerative diseases, combining computational modeling with experimental validation.

Recent publications highlight her work on dual enzyme inhibitors (carbonic anhydrase/VEGFR-2), PDEδ inhibitors for oncogenic Ras repression, and plant-derived wound healing agents. These studies reflect expertise in anticancer and antimicrobial drug design, molecular docking, and natural product screening.

Scientific Awards:

• Full Fellowship in Teaching (Higher Education Academy, UK, 2022)
• Trusted Reviewer Certificate (International Journal of Molecular Sciences, MDPI, 2023)
• Travel Award (University of Oxford, 2017)
• CARA Research Fellowship (Oxford, 2015-2017)
• Franco-Syrian Scholarship (Paris XI University, 2004-2009)

Hadia actively mentors PhD students and has developed MPharm and MSc programs emphasizing inclusive education and career development. She serves on editorial boards (e.g., Archive of Advanced Chemistry Journal) and promotes science accessibility through her role as a STEM ambassador, participating in outreach initiatives like SoapBox Science.